- Home
- CLOV vs OCUL Comparison
CLOV vs OCUL Comparison
Compare CLOV & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLOV | OCUL |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | 724 | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CLOV | OCUL |
|---|---|---|
| Price | $3.54 | $8.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $2.90 | ★ $23.56 |
| AVG Volume (30 Days) | ★ 7.2M | 2.6M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $1,924,308,000.00 | $1,990,000.00 |
| Revenue This Year | $52.59 | $7.93 |
| Revenue Next Year | $15.37 | $96.07 |
| P/E Ratio | $69.70 | ★ N/A |
| Revenue Growth | ★ 40.34 | 3.48 |
| 52 Week Low | $1.58 | $6.23 |
| 52 Week High | $3.92 | $16.44 |
Technical Indicators
Market Signals| Indicator | CLOV | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 79.79 | 37.00 |
| Support Level | $2.44 | $7.38 |
| Resistance Level | $3.92 | $9.93 |
| Average True Range (ATR) | 0.21 | 0.47 |
| MACD | 0.04 | -0.18 |
| Stochastic Oscillator | 86.73 | 12.22 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.